Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia.

The potent, centrally active, calcium channel antagonist, nimodipine, was utilized in a highly predictive "spinal stroke" model in order to investigate the potential pathophysiological effects of calcium flux in spinal injury, as well as to evaluate the potential therapeutic role of the newly developed dihydropyridine derivatives in ischemic central nervous system injury. Nimodipine, administered before or after ischemia, at doses shown to be effective in improving cerebral blood flow and in dilating central blood vessels, failed to improve either the histopathological changes or the functional deficit caused by temporary aortic occlusion in the unanesthetized rabbit.

[1]  J. Berner.  Cerebral artery spasm — A controlled trial of nimodipine in patients with subarachnoid hemorrhage: Allen GS, Ahn HS, Preziosi TJ, et al N Engl J Med 308:619–624 Mar 1983 , 1983 .

[2]  B. Green,et al.  Neuropeptides in spinal cord injury: Comparative experimental models , 1983, Peptides.

[3]  J D Michenfelder,et al.  Nimodipine Improves Cerebral Blood Flow and Neurologic Recovery after Complete Cerebral Ischemia in the Dog , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  W. Young,et al.  Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. , 1982, Journal of neurosurgery.

[5]  L. Symon,et al.  The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. , 1982, Stroke.

[6]  J. Robertson,et al.  Effect of the calcium antagonist nimodipine on contractile responses of isolated canine basilar arteries induced by serotonin, prostaglandin F2 alpha, thrombin, and whole blood. , 1982, Neurosurgery.

[7]  Nayler Wg.  Calcium antagonism: a new approach. , 1982 .

[8]  J. Holaday,et al.  Thyrotropin-Releasing Hormone Improves Neurologic Recovery after Spinal Trauma in Cats , 1981 .

[9]  J. Holaday,et al.  Endorphins in experimental spinal injury: Therapeutic effect of naloxone , 1981, Annals of neurology.

[10]  A. Harper,et al.  Effect of the Calcium Antagonist, Nimodipine, on Cerebral Blood Flow and Metabolism in the Primate , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  L. Edvinsson,et al.  Effects of Extracellular Calcium and of Calcium Antagonists on the Contractile Responses of Isolated Human Pial and Mesenteric Arteries , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  R. Towart.  The Selective Inhibition of Serotonin‐ Induced Contractions of Rabbit Cerebral Vascular Smooth Muscle by Calcium‐ Antagonistic Dihydropyridines: An Investigation of the Mechanism of Action of Nimodipine , 1981, Circulation research.

[13]  R. Towart,et al.  Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteries. , 1981, European journal of pharmacology.

[14]  Auer Lm.  Pial arterial vasodilation by intravenous nimodipine in cats. , 1981 .

[15]  Y. Fukuuchi,et al.  Effects of nimodipine (Bay e 9736) on cerebral circulation in cats. , 1980, Arzneimittel-Forschung.

[16]  J. Farber,et al.  Calcium dependence of toxic cell death: a final common pathway. , 1979, Science.

[17]  G. Allen,et al.  Cerebral arterial spasm: part 10. Reversal of acute and chronic spasm in dogs with orally administered nifedipine. , 1979, Neurosurgery.